Revenue Recognition (Tables)

9 Months Ended

Sep. 30, 2022

Revenue Recognition

Schedule of disaggregation of revenues by payer types

	Three months ended				Nine months ended
	September 30,				September 30,
	2022		2021		2022		2021
(in thousands)
Insurance carriers	$	174,825	$	132,423	$	507,389	$	351,218
Laboratory and other partners		27,050		17,441		69,929		77,575
Patients		8,762		8,252		25,652		23,665
Total revenues	$	210,637	$	158,116	$	602,970	$	452,458

Schedule of total revenue by geographic area

	Three months ended				Nine months ended
	September 30,				September 30,
	2022		2021		2022		2021
(in thousands)
United States	$	197,066	$	148,033	$	576,169	$	427,804
Americas, excluding U.S.		1,155		1,247		2,426		3,052
Europe, Middle East, India, Africa		4,956		5,598		12,383		14,322
Asia Pacific and Other		7,460		3,238		11,992		7,280
Total revenues	$	210,637	$	158,116	$	602,970	$	452,458

Schedule of beginning and ending balances of accounts receivable and deferred revenues

Schedule of changes in the balance of deferred revenues

	September 30,			September 30,
	2022			2021
(in thousands)
Beginning balance	$	28,722	$	72,930
Increase in deferred revenues		20,268		4,703
Refunds of revenues previously deferred		(337)		(10,000)
Revenue recognized during the period that was included in deferred revenues at the beginning of the period		(7,877)		(32,864)
Revenue recognized from performance obligations satisfied within the same period		(12,439)		(2,396)
Ending balance	$	28,337	$	32,373